| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥6099.3B | ¥5904.6B | +3.3% |
| Operating Income | ¥1375.6B | ¥1427.9B | -3.7% |
| Ordinary Income | ¥1691.7B | ¥1662.0B | +1.8% |
| Net Income | ¥1216.3B | ¥1205.0B | +0.9% |
| ROE | 6.0% | 6.2% | - |
SMC Corporation's FY2026 Q3 consolidated results showed revenue of 609.9 billion yen (YoY +3.3%), operating income of 137.6 billion yen (YoY -3.7%), ordinary income of 169.2 billion yen (YoY +1.8%), and net income of 121.6 billion yen (YoY +0.9%). The company achieved modest top-line growth driven by China recovery (+16% volume growth), while operating profit declined due to rising processing costs (+10.5 billion yen) and selling, general and administrative expenses (+9.7 billion yen). Non-operating income including interest income of 14.0 billion yen and foreign exchange gains of 14.8 billion yen supported ordinary and net income levels. Operating margin compressed to 22.6% from 24.2% in the prior year. The company maintained its full-year guidance of revenue 816.0 billion yen (+3.0%), operating income 183.0 billion yen (-3.8%), and net income 153.0 billion yen.
Revenue growth of +3.3% was primarily driven by China region volume expansion (+16% YoY) and positive foreign exchange effects (+6.8 billion yen), partially offset by declines in Japan and North America. By industry vertical, semiconductor equipment (22% of sales) and automotive (18%) led demand recovery, while medical equipment remained weak across Japan, North America, and Europe. On a sequential basis, Q3 revenue increased +4.8% from Q2, with foreign exchange contributing +6.8 billion yen.
Operating income declined -3.7% despite revenue growth, with operating margin compressing 1.6 percentage points to 22.6%. The primary profit headwinds were processing cost increases of 10.5 billion yen and SG&A expense increases of 9.7 billion yen, which more than offset the gross profit contribution from higher sales volume. Inventory valuation loss improved by 7.7 billion yen compared to the prior year, providing partial relief. Foreign exchange had mixed effects, with euro appreciation providing tailwinds offset by dollar and renminbi depreciation.
Ordinary income increased +1.8% to 169.2 billion yen, exceeding operating income performance due to substantial non-operating income. Interest income totaled 14.0 billion yen and foreign exchange gains reached 14.8 billion yen, collectively adding 28.8 billion yen above the operating level. The gap between ordinary income and net income remained moderate at 47.5 billion yen (28% of ordinary income), primarily driven by income taxes.
Non-recurring factors include the 7.7 billion yen year-over-year improvement in inventory valuation losses, which represents a reversal of prior period charges rather than sustainable operational improvement. Additionally, the 14.8 billion yen foreign exchange gain is subject to currency volatility and should not be considered recurring. Combined, these non-operating and semi-recurring items total approximately 22.5 billion yen, or 18% of net income, indicating that core operational earnings quality requires close monitoring.
The results represent a "revenue up, profit down" pattern, where modest top-line growth failed to translate into operating profit expansion due to cost structure pressures and margin compression. Profitability is being sustained by non-operating income streams rather than operational efficiency improvements.
SMC operates as a single reportable segment in automated control equipment manufacturing. Within this unified business structure, the company provides detailed breakdowns by industry vertical and geographic region that serve as proxy sub-segments for analytical purposes.
By industry vertical, semiconductor equipment represents 22% of revenue and served as the primary growth driver with strong recovery momentum. Automotive accounts for 18% with mixed regional performance (North America recovering, Europe declining). Electrical equipment represents 10%, general machinery 10%, food processing 6%, and medical equipment 5%, with the remaining 29% distributed across other industrial applications. The semiconductor and electrical equipment verticals demonstrated the strongest order momentum, with January 2026 orders up 124% year-over-year.
By geographic region, China represents 31% of consolidated revenue and functioned as the core growth engine with +16% volume growth, significantly outpacing all other regions. Japan accounts for 19% but experienced volume contraction. Europe represents 19% with euro appreciation providing revenue tailwinds despite mixed demand conditions. Other Asia contributes 16% with solid growth momentum, while North America represents 13% with modest recovery trends.
The China region effectively serves as the company's core business driver in the current period, contributing the majority of incremental revenue growth. Operating profit is reported on a consolidated basis without geographic segmentation, but management commentary indicates that processing cost increases (primarily manufacturing-related) and SG&A expansion (distributed across regions) were the primary margin headwinds. The 22.6% consolidated operating margin, while compressed from prior year 24.2%, remains at premium levels reflecting the company's specialized product positioning and pricing power in automated control components.
The concentration of growth in China (31% of revenue with +16% volume) presents both opportunity and geographic concentration risk. The semiconductor and electrical equipment verticals together represent approximately 32% of revenue and drove the January 2026 order surge, indicating that Q4 and FY2027 performance will be heavily dependent on sustained capital equipment investment cycles in these sectors.
Profitability: ROE 6.0% (prior year 6.3%), representing a slight decline but remaining above the company's recent trend. Operating margin 22.6% (prior year 24.2%), compressing 1.6 percentage points due to processing cost and SG&A increases. Net profit margin 19.9% (prior year 20.4%), remaining at elevated levels supported by non-operating income. Gross profit margin 45.3% (cost of sales ratio 54.7%), indicating sustained product-level pricing power despite cost pressures.
Cash Quality: Operating cash flow data is not disclosed in the quarterly filing, preventing calculation of the OCF/Net Income ratio. The absence of this metric limits the ability to assess earnings quality through cash conversion analysis.
Investment: CapEx for the nine-month period totaled 127.7 billion yen (80.1 billion yen domestic, 39.1 billion yen overseas) against annual plan of 180.0 billion yen, representing 71% progress. Depreciation and amortization for the period is not separately disclosed, preventing calculation of the CapEx/D&A ratio. The substantial capital investment program focuses on manufacturing facilities (Tono, Tsukuba, Shimozuma plants), development centers (New Technology Center with 80.4 billion yen allocation), and overseas production sites (Vietnam, China, United States).
Financial Health: Equity ratio 90.6% (prior year 91.8%), remaining at exceptionally high levels indicating conservative capital structure. Current ratio 900.4% (current assets 1,470.5 billion yen / current liabilities 163.3 billion yen), reflecting substantial liquidity cushion. Cash and deposits 655.7 billion yen, representing 29% of total assets and providing extensive financial flexibility. Debt-to-equity ratio 1.7% (total interest-bearing debt 35.1 billion yen / equity 2,042.4 billion yen), indicating minimal leverage.
Per Share Metrics: Basic EPS 1,916.97 yen (prior year 1,880.28 yen, +2.0%), modestly outpacing net income growth due to average share count reduction. Book value per share (BPS) can be calculated as 32,104 yen (equity 2,042.4 billion yen / outstanding shares 63,869 thousand shares including treasury).
Operating cash flow data is not disclosed in the quarterly XBRL filing, preventing comprehensive cash flow analysis. This represents a significant information gap for assessing earnings quality and cash generation capability.
Investing cash flow is indirectly observable through capital expenditure of 127.7 billion yen for the nine-month period (71% of annual 180.0 billion yen plan). Major allocations include 80.1 billion yen for domestic facilities (New Technology Center, manufacturing plants at Tono, Tsukuba, Shimozuma) and 39.1 billion yen for overseas expansion (Vietnam, China, United States production sites, sales and logistics facilities across Taiwan, Australia, Malaysia, Korea, Europe). The substantial investment program indicates growth-phase capital allocation focused on capacity expansion and technology development.
Financing cash flow is partially observable through dividend payments. With annual dividend of 500 yen per share (interim 500 yen paid, year-end 500 yen planned) and approximately 63,447 thousand average shares, total dividend outflow approximates 31.7 billion yen annually.
Working capital indicators show concerning trends. Days Sales Outstanding (DSO) reached 128 days, indicating extended receivable collection periods. Days Inventory Outstanding (DIO) deteriorated sharply to 556 days, reflecting substantial inventory accumulation relative to cost of sales. Days Payables Outstanding (DPO) was 38 days. The resulting cash conversion cycle (CCC) of 646 days (128 + 556 - 38) represents a severe working capital efficiency challenge, tying up substantial cash in operations.
Free cash flow cannot be calculated due to missing operating cash flow data. However, the combination of 655.7 billion yen cash holdings against modest debt levels (35.1 billion yen short-term borrowings) and planned annual dividends of approximately 31.7 billion yen suggests adequate near-term liquidity for shareholder returns and capital investment programs.
Cash generation assessment: Needs Monitoring. While the substantial cash balance provides financial flexibility, the extreme deterioration in working capital metrics (particularly 556-day DIO and 646-day CCC) signals potential operational inefficiencies or demand-supply mismatches that could constrain future cash generation if not addressed. The absence of disclosed operating cash flow data prevents definitive assessment of whether current earnings are backed by commensurate cash generation.
Ordinary income of 169.2 billion yen exceeded operating income of 137.6 billion yen by 31.6 billion yen (23% premium), driven by non-operating income components. Interest income contributed 14.0 billion yen, reflecting returns on the substantial cash and investment portfolio. Foreign exchange gains totaled 14.8 billion yen, resulting from yen depreciation effects on foreign currency-denominated assets and transactions. The combined non-operating income of approximately 28.8 billion yen represents 21% of ordinary income, indicating material reliance on non-core income streams.
The 14.8 billion yen foreign exchange gain is inherently non-recurring in nature, subject to currency market volatility. Management's exchange rate sensitivities indicate that 1% movements in dollar, euro, and renminbi rates impact operating profit by 0.24 billion yen, 0.72 billion yen, and 1.12 billion yen respectively, demonstrating significant earnings volatility potential from FX fluctuations.
Additionally, inventory valuation loss improved by 7.7 billion yen year-over-year, providing a one-time boost to operating profit. This represents a reversal of prior period charges rather than sustainable margin improvement, and should be considered semi-recurring relief rather than core operational enhancement.
Combining the non-recurring foreign exchange gain (14.8 billion yen) and semi-recurring inventory valuation improvement (7.7 billion yen), approximately 22.5 billion yen or 18.5% of net income (121.6 billion yen) derives from non-sustainable or volatile sources. Adjusting for these factors, normalized net income approximates 99 billion yen, suggesting that core operational earnings power is approximately 19% below reported levels.
Accruals and cash conversion represent a critical earnings quality concern. Operating cash flow data is not disclosed, preventing direct OCF/Net Income comparison. However, the severe working capital deterioration evident in balance sheet trends (DSO 128 days, DIO 556 days, CCC 646 days) strongly suggests that reported earnings are not fully converting to cash. The 195.7 billion yen inventory balance increased substantially, and accounts receivable collection appears extended, both indicating that accrued revenues and profits may not be realized in cash on a timely basis.
Overall earnings quality assessment: Moderate concern. While reported profitability metrics remain strong, the substantial contribution from non-operating and non-recurring sources (approximately 18.5% of net income), combined with working capital deterioration signaling weak cash conversion, indicate that core sustainable earnings power is materially below reported levels. Investors should focus on normalized operating profit trends and monitor working capital metrics closely for signs of improvement.
SMC maintained its full-year FY2026 guidance unchanged: revenue 816.0 billion yen (+3.0% YoY), operating income 183.0 billion yen (-3.8% YoY), ordinary income 209.0 billion yen (-0.4% YoY), and net income 153.0 billion yen (+0.5% YoY).
Progress rate analysis at Q3 (nine months): Revenue 609.9 billion yen represents 74.7% of full-year guidance (standard expectation 75%), operating income 137.6 billion yen represents 75.2% (standard 75%), ordinary income 169.2 billion yen represents 80.9% (standard 75%), and net income 121.6 billion yen represents 79.5% (standard 75%). Revenue and operating income are tracking in line with linear expectations, while ordinary and net income are running ahead of schedule due to strong non-operating income contributions in the first nine months.
To achieve full-year guidance, Q4 (fourth quarter) requires: revenue 206.1 billion yen (representing 25.3% of annual target), operating income 45.4 billion yen (24.8%), ordinary income 39.8 billion yen (19.1%), and net income 31.4 billion yen (20.5%). The implied Q4 operating income requirement is in line with seasonal patterns, while ordinary and net income requirements are below Q1-Q3 run rates, suggesting management expects moderation in non-operating income contributions or is building conservative cushion.
Key drivers supporting guidance achievement include the sharp recovery in order momentum, with January 2026 orders up 124% year-over-year (index 124 vs. base 100). Semiconductor equipment and electrical equipment sectors showed particularly strong order recovery across all regions. China region orders surged, with other Asia also demonstrating solid momentum. Management commentary emphasizes that the order recovery in semiconductor capital equipment and China market demand supports Q4 revenue expectations.
Downside risks to guidance include potential moderation in foreign exchange gains (Q1-Q3 benefited from 14.8 billion yen FX gains), ongoing processing cost increases (10.5 billion yen headwind in Q1-Q3), and uncertainty regarding sustainability of the January order surge into February-March period. The medical equipment vertical remains weak across major geographies, and automotive sector shows regional divergence (North America recovering, Europe weak).
Management maintained its full-year exchange rate assumptions of 147.10 yen/dollar, 172.00 yen/euro, and 20.60 yen/renminbi. Q3 actual rates were 148.67 yen/dollar, and 20.76 yen/renminbi, broadly in line with assumptions.
Overall assessment: Guidance appears achievable based on 75% progress rates for revenue and operating income, with strong order momentum providing forward visibility. The conservative implied Q4 ordinary and net income targets suggest management is appropriately cautious regarding non-operating income sustainability. Investors should monitor February-March order trends to confirm that the January surge represents a sustained recovery rather than a one-time spike.
SMC announced an interim dividend of 500 yen per share for the six-month period ended September 30, 2025, and maintains year-end dividend guidance of 500 yen per share, resulting in total annual dividend of 500 yen per share (unchanged from prior year). Based on net income of 121.6 billion yen and approximately 63,447 thousand average shares, the dividend payout ratio is approximately 26.0% for the nine-month period (annual dividend 500 yen per share / annualized EPS 1,917 yen). Using full-year guidance of net income 153.0 billion yen, the implied annual payout ratio is approximately 20.8% (500 yen / 2,407 yen EPS guidance).
The 20.8% payout ratio is conservative relative to typical Japanese manufacturing company practices and well below the 60% threshold generally considered sustainable. Combined with the substantial cash balance of 655.7 billion yen (29% of total assets) and minimal debt (35.1 billion yen), dividend sustainability appears secure in the near term despite the absence of disclosed operating cash flow data.
Treasury share balance increased by 181.3 billion yen in book value terms (from 219.7 billion yen to 401.0 billion yen), representing an 82.5% increase. However, specific share buyback activity details and total return ratio (dividends plus buybacks as a percentage of net income) cannot be calculated from available disclosures. The treasury share increase may reflect buyback programs or accounting adjustments, but requires additional disclosure for definitive interpretation.
Dividend policy remains stable with the 500 yen annual dividend maintained consistently. Management has not announced changes to shareholder return policy or specific total return targets. The conservative payout ratio and strong balance sheet suggest substantial capacity for increased returns, but management appears to be prioritizing capital investment (180.0 billion yen annual CapEx plan) to support long-term growth initiatives including the New Technology Center and global manufacturing expansion.
Shareholder return assessment: Stable and sustainable, but conservative relative to financial capacity. The low payout ratio and substantial cash holdings indicate room for enhanced returns. However, the severe working capital deterioration (646-day cash conversion cycle) may be constraining management's willingness to increase distributions until operational efficiency improves. Investors seeking higher cash returns may view the conservative policy as suboptimal capital allocation, while those prioritizing long-term growth may appreciate the investment-focused strategy.
Near-term:
Long-term:
Industry Position (Reference - Proprietary Analysis)
Profitability: ROE 6.0% exceeds industry median 5.8% (Q3 2025, n=105 manufacturing companies) but is below the upper quartile of 8.4%, indicating above-average but not top-tier equity returns. Operating margin 22.6% substantially exceeds industry median 8.9% (Q3 2025, n=105) and ranks in the top decile, reflecting SMC's specialized product positioning and pricing power in automated control equipment.
Financial Health: Equity ratio 90.6% far exceeds industry median 63.8% (Q3 2025, n=105) and represents one of the strongest balance sheets in the manufacturing sector. Current ratio 900.4% dramatically exceeds industry median 287% (Q3 2025, n=84), indicating exceptional liquidity and conservative financial management.
Efficiency: Asset turnover 0.270 (revenue 609.9 billion yen / total assets 2,255.1 billion yen) significantly underperforms industry median 0.56 (Q3 2025, n=105), ranking in the bottom quartile. This reflects the company's substantial cash holdings and working capital inefficiencies. Net profit margin 19.9% substantially exceeds industry median 6.5% (Q3 2025, n=105) and ranks in the top decile, demonstrating superior profitability despite efficiency challenges.
Working Capital: Inventory turnover 556 days dramatically underperforms industry median 112 days (Q3 2025, n=97), ranking among the weakest in the sector and indicating severe inventory management challenges. Receivables turnover 128 days exceeds industry median 85 days (Q3 2025, n=104), suggesting extended collection periods. Cash conversion cycle 646 days far exceeds industry median 111 days (Q3 2025, n=104), representing a critical operational efficiency gap.
Growth: Revenue growth +3.3% aligns with industry median 2.8% (Q3 2025, n=105), indicating in-line top-line momentum. EPS growth +2.0% trails the industry median 9.0% (Q3 2025, n=104), suggesting earnings momentum is below sector average despite revenue growth.
Industry comparison summary: SMC exhibits a distinctive profile of exceptional profitability (operating margin 22.6% vs. industry 8.9%) and financial strength (equity ratio 90.6% vs. industry 63.8%) combined with severe operational efficiency challenges (asset turnover 0.270 vs. industry 0.56, DIO 556 days vs. industry 112 days). The company's specialized automated control equipment market position enables premium margins and conservative financial management, but working capital management represents a critical competitive disadvantage requiring management priority. Industry: Manufacturing sector (105 companies), Comparison: Q3 2025 fiscal periods, Source: Proprietary analysis.
Working capital deterioration and cash conversion risk: Days Inventory Outstanding of 556 days (vs. industry median 112 days) and Cash Conversion Cycle of 646 days (vs. industry median 111 days) represent severe operational inefficiency that ties up substantial cash in operations. The DIO level is nearly 5x industry median, suggesting potential inventory obsolescence risk, demand-supply mismatches, or fundamental operational control issues. If not corrected, this could constrain future cash generation, force increased external financing, and pressure dividend sustainability despite current strong cash reserves. Quantified impact: approximately 400-500 billion yen of excess working capital trapped relative to industry-normal levels.
Operating leverage deterioration and margin compression risk: Operating margin declined from 24.2% to 22.6% (down 1.6 percentage points) despite revenue growth of +3.3%, indicating negative operating leverage. Processing costs increased 10.5 billion yen and SG&A expenses rose 9.7 billion yen, overwhelming gross profit contribution from volume growth. With the company's high fixed cost structure from substantial CapEx investments (180.0 billion yen annual plan), further volume deceleration or cost inflation would accelerate margin compression. Management's full-year guidance implies Q4 operating margin of approximately 22.0% (45.4 billion yen operating income / 206.1 billion yen revenue), suggesting ongoing pressure.
Geographic and end-market concentration risk: China region represents 31% of revenue and generated +16% volume growth, functioning as the primary growth engine. Semiconductor equipment vertical represents 22% of revenue and led the January 2026 order surge (124% year-over-year). The concentration of growth momentum in a single geography (China) and cyclical end-market (semiconductor capital equipment) creates vulnerability to geopolitical disruptions, China economic slowdown, or semiconductor investment cycle downturn. Management's FX sensitivity analysis indicates 1% renminbi movement impacts operating profit by 1.12 billion yen (highest among currencies), quantifying the China exposure. Additionally, US tariff policies or China-Taiwan geopolitical tensions represent material tail risks to this concentrated growth driver.
Short-term debt refinancing risk: Short-term borrowings surged from 5.0 billion yen to 35.1 billion yen (+30.0 billion yen, +596%), while the short-term debt ratio reached 100% (all interest-bearing debt is short-term). Although the company maintains substantial liquidity (cash 655.7 billion yen, current ratio 900.4%), the shift to short-term funding exposes the company to refinancing risk and interest rate volatility. The presentation materials do not explain the purpose or terms of this borrowing increase, creating disclosure transparency concerns. Management should clarify whether this reflects operational funding needs (suggesting working capital pressure) or deliberate treasury management.
Return on equity and capital efficiency constraints: ROE of 6.0% only marginally exceeds industry median 5.8% despite operating margins nearly 3x industry levels (22.6% vs. 8.9%), indicating that exceptional profitability is being diluted by poor capital efficiency. DuPont decomposition shows asset turnover of 0.270 (vs. industry 0.56) as the primary drag, driven by excess cash holdings (655.7 billion yen, 29% of assets) and working capital inefficiency (DIO 556 days). Financial leverage of 1.10x (total assets / equity) is well below industry median 1.53x, reflecting ultra-conservative capitalization that constrains ROE. Combined, these factors suggest that the company's economic returns are substantially below potential, representing an implicit financial risk of value destruction through suboptimal capital allocation.
Foreign exchange volatility risk: Ordinary income of 169.2 billion yen included 14.8 billion yen of FX gains (8.7% of ordinary income), demonstrating material earnings sensitivity to currency movements. Management disclosed FX sensitivities of 0.24 billion yen per 1% dollar movement, 0.72 billion yen per 1% euro movement, and 1.12 billion yen per 1% renminbi movement on operating profit. For FY2026 Q3 results, yen depreciation provided tailwinds, but reversal to yen appreciation would create substantial headwinds. With China representing 31% of revenue and renminbi having highest sensitivity (1.12 billion yen per 1%), sustained renminbi depreciation or capital controls would materially impact profitability. The company does not extensively disclose hedging programs in available materials, suggesting potential limited protection against adverse movements.
Premium profitability sustained by non-operating income, raising concerns about core earnings power: SMC demonstrated operating margin of 22.6%, substantially exceeding manufacturing industry median of 8.9% and ranking in the top decile of sector peers. However, operating profit declined -3.7% year-over-year despite revenue growth of +3.3%, indicating negative operating leverage and margin compression. Profitability at the ordinary and net income levels was supported by 14.8 billion yen of foreign exchange gains and 14.0 billion yen of interest income, collectively representing 21% of ordinary income. Excluding non-recurring FX gains and inventory valuation improvement (7.7 billion yen), normalized net income approximates 99 billion yen, approximately 19% below reported 121.6 billion yen. This earnings structure indicates that core operational profitability is under pressure from rising processing costs and SG&A expenses, masked by temporary non-operating income contributions. The key takeaway is that while reported profitability metrics appear strong, sustainable operational earning power requires improvement in cost structure and operating leverage to maintain premium margins without reliance on FX tailwinds.
Severe working capital inefficiency represents critical operational and cash generation challenge: Days Inventory Outstanding reached 556 days (nearly 5x industry median of 112 days) and cash conversion cycle deteriorated to 646 days (vs. industry median 111 days), representing one of the weakest working capital profiles in the manufacturing sector. Combined with Days Sales Outstanding of 128 days, the company has approximately 400-500 billion yen of excess capital trapped in working capital relative to industry-normal efficiency levels. This structural inefficiency constrains return on equity (6.0%, only marginally above industry median 5.8% despite premium operating margins), reduces cash conversion quality, and limits financial flexibility for capital allocation. The balance sheet shows inventory of 195.7 billion yen increasing from prior levels, while operating cash flow data remains undisclosed in quarterly filings. The critical observation is that SMC's financial performance is characterized by exceptional product-level profitability but severe operational execution weaknesses in inventory and receivables management. Resolution of working capital issues represents the single most important operational priority and would unlock substantial value through improved ROE, cash generation, and capital allocation flexibility.
Strong order momentum and China recovery provide near-term cyclical support, but sustainability warrants monitoring: January 2026 orders surged to index 124 (base 100), representing +24% year-over-year growth driven by semiconductor equipment and electrical equipment sectors across all geographies. China region, representing 31% of revenue, delivered +16% volume growth in Q3 and led the order recovery. Management maintained full-year guidance with confidence, and the 71% progress rate for revenue and operating income at Q3 indicates guidance is on track. The substantial order recovery, if sustained through Q4 and into FY2027, would support revenue acceleration and potential margin recovery as fixed costs are absorbed over higher volumes. However, the sustainability of this momentum faces several risks: the concentration of growth in China (31% revenue share) and semiconductor equipment (22% revenue share) creates single-geography and single-end-market dependencies; medical equipment vertical remains weak across major geographies; and automotive shows regional divergence. The forward-looking implication is that near-term earnings should benefit from cyclical recovery momentum, but investors should closely monitor February-March order trends to distinguish between temporary inventory restocking versus sustained end-demand recovery, and assess management's FY2027 guidance when announced for evidence of structural improvement versus cyclical rebound.
This report was automatically generated by AI integrating XBRL earnings data and PDF presentation materials as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.
AI analysis of PDF earnings presentation
For SMC Corporation’s FY March 2026 third quarter results, revenue was 6,099億円 (+3.3% YoY) and operating profit was 1,375億円 (-3.7%). Greater China led with a +3.0% increase on a volume basis, while Japan and North America declined. The primary drivers of the operating profit decrease were a 105億円 increase in processing costs and a 97億円 increase in SG&A expenses. In foreign exchange, euro strength in Europe contributed positively, while a weaker U.S. dollar and Chinese yuan were headwinds. Orders in January 2026 rebounded sharply to 124% YoY, with semiconductors and electronics increasing across all regions. Capex progress stands at 71% against the full-year plan of 1,800億円. Full-year guidance is unchanged, with revenue of 8,160億円 and operating profit of 1,830億円.
From 2Q to 3Q standalone, revenue increased +4.8%, with a sizable FX tailwind contributing +68億円. Greater China achieved double-digit growth, with sales volume up +16% YoY. The order index in January 2026 recovered sharply to 124 (prior year = 100), led by semiconductor-related demand. Planned capex totals 801億円, comprising 410億円 domestic and 391億円 overseas, to expand manufacturing and R&D sites. Inventory valuation losses improved by 77億円 YoY, lifting profit.
Full-year guidance is maintained at revenue of 8,160億円 (+3%) and operating profit of 1,830億円 (-3.8%). Orders in January 2026 rebounded sharply, up +24% YoY, with a pronounced recovery in capex for semiconductors and electronics. By region, Greater China and the rest of Asia are driving growth. In autos, North America is recovering while Europe remains soft. Healthcare remains soft in Japan, North America, and Europe. A recovery in orders from 4Q onward is key to achieving full-year targets.
Management sees a recovery in semiconductor and machine tool demand in Greater China and views the sharp jump in January orders as a positive. Meanwhile, to address higher processing costs and increased fixed-cost burden, it will continue to drive production efficiency. FX assumptions for the full year are USD 147.10, EUR 172.00, and CNY 20.60. While maintaining the improving trend in inventory valuation losses, the company intends to focus on improving working capital efficiency.
Proactive investment in manufacturing sites: domestically at the Tono, Tsukuba, and Shimotsuma plants, and internationally with a focus on Vietnam, China (Tianjin and Beijing), and the U.S. Strengthening development sites: expansion of the R&D framework centered on the new Technology Center (domestic plan of 804億円). Expansion of sales and logistics sites: investments in Taiwan, Australia, China sales subsidiary, Malaysia, South Korea, European warehouse, and Germany. By region, strengthening local production and sales to maximize growth opportunities in Greater China. Broaden the product lineup to capture the recovery in semiconductor and electronics demand.
Processing costs continue to rise, making cost control essential to maintain operating margin. Demand volatility risk from regional divergence in autos (recovery in North America, decline in Europe). FX risk: a weaker USD and CNY compress earnings; a 1% move can impact operating profit by up to 31.2億円. Continued softness in the healthcare sector with unclear timing of recovery. Geopolitical risks such as U.S. tariff policy may affect future performance.